A Hard Truth to Swallow: Critically Evaluating the MD Anderson Dysphagia Inventory (MDADI) as an Endpoint in Human Papillomavirus-associated Oropharyngeal Cancer Trials
International Journal of Radiation Oncology*Biology*Physics · 2024-11 · 120 (3) · 805-822
DOI: 10.1016/j.ijrobp.2024.05.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024-11. Verfasst von Lachlan McDowell und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Australia. Electronic address: Lachlan.mcdowell@health.qld.gov.au. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Deglutition Disorders, Quality of Life, Patient Reported Outcome Measures. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 65 Literaturangaben.
Themen: Dysphagie
Abstract (Originalsprache)
The MD Anderson Dysphagia Inventory (MDADI), a measure of swallowing-related quality of life, has become the preferred patient-reported outcome measure (PROM) in contemporary clinical trials evaluating the experience of human papillomavirus-associated oropharyngeal squamous cell carcinoma (HPVOPSCC) survivors. With many potentially practice-changing studies using the MDADI composite score as either a primary or coprimary endpoint, or as a key secondary endpoint, it is important to understand its psychometric properties as judged by contemporary PROM standards, with a particular focus on its application to contemporary HPVOPSCC populations. In this critical review, we evaluate contemporary HPVOPSCC studies reporting MDADI outcomes, followed by a detailed evaluation of the psychometric properties of the MDADI. Although the focus of this review was the MDADI, the issues discussed are not unique to the MDADI and have broader applicability to the evaluation and assessment of other PROMs currently in use. First, it may be possible to improve administration of the instrument, as related to missing items, scoring, and the number of items required. Second, although in many instances, the MDADI has been intended as a direct or surrogate measure of swallowing physiology, the MDADI composite score captures a broader health-related quality of life construct affected by both swallowing and eating, the latter of which may be affected by a range of nonswallowing treatment-related toxicities. Finally, a clinically meaningful change of 10 in the MDADI composite score, widely accepted and applied to the clinical trial setting, represents an undoubtably clinically relevant difference in unselected head and neck cancer survivors. However, the smallest difference that might be clinically important to a highly functional HPVOPSCC cohort remains uncertain. Understanding the purpose and properties of the MDADI instrument and furthering the sophistication with which we apply it in this population would improve its interpretation in clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Australia. Electronic address: Lachlan.mcdowell@health.qld.gov.au.
- University of Sydney, School of Psychology, Sydney, New South Wales, Australia.
- Department of Head and Neck Surgery, Division of Surgery, and Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
- Department of Radiation Oncology, University of California San Francisco, San Francisco, California; Helen Diller Family Comprehensive Cancer Center, San Francisco, California.
- Genesiscare St Vincent's Hospital, Melbourne, Australia; Department of Medicine, University of Melbourne, Melbourne, Australia.
Zitieren
APA
McDowell, L., King, M. T., Hutcheson, K. A., Ringash, J., Yom, S. S., Corry, J., Henson, C., Mehanna, H., & Rischin, D. (2024). A Hard Truth to Swallow: Critically Evaluating the MD Anderson Dysphagia Inventory (MDADI) as an Endpoint in Human Papillomavirus-associated Oropharyngeal Cancer Trials. International Journal of Radiation Oncology*Biology*Physics, 120(3), 805-822. https://doi.org/10.1016/j.ijrobp.2024.05.005
Vancouver
McDowell L, King MT, Hutcheson KA, Ringash J, Yom SS, Corry J, et al. A Hard Truth to Swallow: Critically Evaluating the MD Anderson Dysphagia Inventory (MDADI) as an Endpoint in Human Papillomavirus-associated Oropharyngeal Cancer Trials. International Journal of Radiation Oncology*Biology*Physics. 2024;120(3):805-822. doi:10.1016/j.ijrobp.2024.05.005
BibTeX
@article{McDowell2024,
author = {McDowell, Lachlan and King, Madeleine T and Hutcheson, Katherine A and Ringash, Jolie and Yom, Sue S and Corry, June and Henson, Christina and Mehanna, Hisham and Rischin, Danny},
title = {A Hard Truth to Swallow: Critically Evaluating the MD Anderson Dysphagia Inventory (MDADI) as an Endpoint in Human Papillomavirus-associated Oropharyngeal Cancer Trials},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2024},
volume = {120},
number = {3},
pages = {805--822},
doi = {10.1016/j.ijrobp.2024.05.005}
}
EUVIMED